tiprankstipranks
Trending News
More News >

Steven H Stein Insider Profile

11 Followers
Steven H Stein, EVP & Chief Medical Officer at Incyte, holds 63.13K shares in Incyte (Ticker: INCY), holds ― shares in Kura Oncology (Ticker: KURA), holds ― shares in Theseus Pharmaceuticals (Ticker: THRX). Most recently, Steven H Stein Sold ― shares of Incyte on Dec 03, 2025 for an estimated value of $4.07M.
tipranks
Steven H Stein

Steven H Stein
Incyte (INCY)
EVP & Chief Medical Officer

Ranked #91,195 out of 104,449 Corporate Insiders

Profitable Transactions

29%
2 out of 7 Profitable Transactions

Average Return

-26.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
100.00%
0.00%
0.00%
A breakdown of Steven H Stein's holdings

Insider Roles

Incyte
(INCY)
EVP & Chief Medical Officer
Kura Oncology
(KURA)
Director
Repare Therapeutics
(RPTX)
Director
Roles that Steven H Stein holds in companies

Most Profitable Insider Trade

Stock:
Incyte
(INCY)
Rating:Informative Sell
Date:Nov 07, 2025 - Today
Return:+1.70%
The most profitable trade made by Steven H Stein

Steven H Stein's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Incyte
Dec 03, 2025
EVP & Chief Medical Officer
Informative Sell
4.07M
$6.40M
Kura Oncology
Director
THRX
Theseus Pharmaceuticals
Repare Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Steven H Stein's performance on stock

Steven H Stein insider profile FAQ

What is the percentage of profitable transactions made by Steven H Stein?
The percentage of profitable transactions made by Steven H Stein is 29%.
    What is the average return per transaction made by Steven H Stein?
    The average return per transaction made by Steven H Stein is -26.60%.
      What stocks does Steven H Stein hold?
      Steven H Stein holds: INCY, KURA, THRX, RPTX stocks.
        What was Steven H Stein’s latest transaction?
        Steven H Stein latest transaction was an Informative Sell of $4.07M.
          What was Steven H Stein's most profitable transaction?
          Steven H Stein’s most profitable transaction was an Informative Sell of INCY stock on November 7, 2025. The return on the trade was 1.70%.
            What is Steven H Stein's role in Incyte?
            Steven H Stein's role in Incyte is EVP & Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.